Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells.
Goodspeed A, Bodlak A, Duffy AB, Nelson-Taylor S, Oike N, Porfilio T, Shirai R, Walker D, Treece A, Black J, Donaldson N, Cost C, Garrington T, Greffe B, Luna-Fineman S, Demedis J, Lake J, Danis E, Verneris M, Adams DL, Hayashi M. Goodspeed A, et al. Among authors: adams dl. bioRxiv [Preprint]. 2024 Jun 20:2024.01.18.576251. doi: 10.1101/2024.01.18.576251. bioRxiv. 2024. PMID: 38293103 Free PMC article. Preprint.
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.
Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM. Dhir A, et al. Among authors: adams dl. Clin Cancer Res. 2024 Dec 2;30(23):5314-5322. doi: 10.1158/1078-0432.CCR-24-1339. Clin Cancer Res. 2024. PMID: 39360936 Clinical Trial.
Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy.
Iwase T, Parikh A, Wenli D, Shen Y, Adams DL, Tang CM, Cohen EN, Reuben JM, Shrimanker TV, Chainitikun S, Kida K, Raghavendra AS, Sapon ME, Sahin O, James A, Sridhar N, Klopp AH, Tripathy D, Ueno NT. Iwase T, et al. Among authors: adams dl. J Cancer. 2024 Sep 16;15(18):5855-5862. doi: 10.7150/jca.89453. eCollection 2024. J Cancer. 2024. PMID: 39440056 Free PMC article.
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.
Wiseman CL, Holmes JP, Calfa C, Dakhil SR, Bhattacharya S, Peoples GE, Lacher MD, Lopez-Lago M, Kharazi A, Del Priore G, Chang M, Adams DL, Williams WV. Wiseman CL, et al. Among authors: adams dl. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379864. doi: 10.1080/21645515.2024.2379864. Epub 2024 Aug 20. Hum Vaccin Immunother. 2024. PMID: 39165083 Free PMC article. Clinical Trial.
354 results